Status:

COMPLETED

The Impact of Dietary Habits and Nutrition Intervention on Metabolic Syndrome in Individuals With Schizophrenia

Lead Sponsor:

Tamara Sorić

Collaborating Sponsors:

University of Zagreb

Conditions:

Metabolic Syndrome

Eligibility:

All Genders

18-67 years

Phase:

NA

Brief Summary

Metabolic syndrome is a term used to describe a complex clinical condition that includes abdominal obesity, increased level of serum triglycerides, elevated blood pressure, decreased level of high-den...

Eligibility Criteria

Inclusion

  • the diagnosis of schizophrenia according to the 10th Revision of the International Classification of Diseases (ICD-10)
  • age 18-67
  • the diagnosis of metabolic syndrome according to the Joint Interim Statement definition
  • taking antipsychotic medication for the last 6 months or more
  • a stable phase of schizophrenia
  • provided written informed consent (for participants deprived of legal capacity, provided written informed consent of both the participants and their legal guardians)

Exclusion

  • older than 67
  • without the diagnosis of schizophrenia and/or metabolic syndrome
  • following one of the specific hospital diets with the restrictions related to the intake of specific food items, groups or nutrients
  • taking medications for the reduction of body weight
  • significant body weight loss in the past 3 months
  • refusing to provide written informed consent
  • on personal request
  • deterioration in participant's mental state
  • the occurrence of a new illness that could unable full participation in the study or could have an interfering effect
  • a significant change in pharmacological therapy during the intervention period
  • cognitive impairments that unable full participation in the study
  • lack of interest or refusal to fully participate in the study
  • hospital discharge during the intervention period

Key Trial Info

Start Date :

May 2 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2017

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT04025073

Start Date

May 2 2017

End Date

December 20 2017

Last Update

July 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Psychiatric Hospital Ugljan

Ugljan, Croatia, 23275